In early clinical trials, patients on GLP-1 agonists have achieved weight loss of 1520%, compared to the 510% typically seen with previous medications. Holistic approach to GLP-1 drugs Beyond weight loss, GLP-1 agonists have demonstrated the ability to reduce major cardiovascular events, combat fatty liver disease and alleviate obesity-related complications such as knee pain, sleep apnea, and acid reflux
The information contained herein is based on our current knowledge and contains scientific, quality, and technical information to help our trade customers understand more about our ingredients and the science behind them
Error 1: using the old concentration with a new vial This is the most dangerous mistake
typically, improvements are noticed 6-8 weeks after a session
Without a loading dose, it would take months to achieve a therapeutic effect, which is likely clinically unacceptable
Our other products, like our popular GHK-Cu Copper Peptide, also rely on high-quality solvents for proper reconstitution
